Jay Mukesh Chudasama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jay Mukesh Chudasama has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ghanshyam Parmar
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara-391760, Gujarat, India
7 shared publications - Ashish Shah
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara, India
2 shared publications Chintan Aundhia
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, AT & Po Piparia, Waghodia, Vadodara, Gujarat, India
2 shared publications- Chintan Aundhia
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara, 391760, Gujarat, India
2 shared publications - Rajesh A. Maheshwari
Department of Pharmacy Sumandeep Vidyapeeth Deemed to be University Vadodara Gujarat India
2 shared publications - Ashish Patel
Department of Pharmaceutical chemistry, Parul institute of pharmacy, Parul University, Vadodara-391760, Gujarat, India
1 shared publication
Latest Publications
- 5 May 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (5) , 8181-8198
Integrated in vitro and in silico evaluation of rutin as a potential modulator of wound healing pathways
Wound healing is a multifactorial biological process that requires the coordinated regulation of inflammation, cell migration, angiogenesis, growth, and extracellular matrix remodeling. These drawbacks of existing wound care treatments prompt the need to seek safe and cost-effective agents and multi-target agents. This was demonstrated in a study that investigated the wound-healing capacity of a natural flavonoid glycoside, rutin, using an integrated in vitro-in silico methodology. An MTT assay was used to determine the cytocompatibility of rutin in L929 fibroblast cells, and the results showed that cell viability was high at a wide range of concentrations. A scratch wound healing assay showed enhanced fibroblast migration and wound closure in a concentration-dependent manner, and wound contraction was nearly complete within 72 h at optimum concentrations. To understand the molecular mechanisms underlying these effects, network pharmacological analysis revealed 94 common targets between rutin-associated wound healing and rutin-associated genes. Protein-protein interaction analysis identified key regulatory nodes, such as PIK3R1, PRKCA, and EGFR, which are central to the pathways that regulate cell proliferation, migration, angiogenesis, and inflammatory regulation. Enrichment analysis of gene ontology and KEGG pathways revealed that the PI3K-Akt, MAPK, VEGF, and AGE-RAGE signaling pathways were highly involved. Molecular docking showed good binding affinities of rutin to PIK3R1, PRKCA, and EGFR, which was also confirmed by 100 ns molecular dynamics simulations that revealed complex stability and favorable conformational behavior. Density functional theory analysis showed that the electronic characteristics were in line with the antioxidant activity and the strong intermolecular interactions. Together, these results demonstrate that rutin is a promising multifunctional topical wound-healing agent and provide mechanistic evidence for its use in topical therapeutic applications.
- 5 May 2026
- Published by Springer Nature in Molecular Diversity
- Vol. 30 (5) , 8181-8198
Integrated in vitro and in silico evaluation of rutin as a potential modulator of wound healing pathways
Wound healing is a multifactorial biological process that requires the coordinated regulation of inflammation, cell migration, angiogenesis, growth, and extracellular matrix remodeling. These drawbacks of existing wound care treatments prompt the need to seek safe and cost-effective agents and multi-target agents. This was demonstrated in a study that investigated the wound-healing capacity of a natural flavonoid glycoside, rutin, using an integrated in vitro-in silico methodology. An MTT assay was used to determine the cytocompatibility of rutin in L929 fibroblast cells, and the results showed that cell viability was high at a wide range of concentrations. A scratch wound healing assay showed enhanced fibroblast migration and wound closure in a concentration-dependent manner, and wound contraction was nearly complete within 72 h at optimum concentrations. To understand the molecular mechanisms underlying these effects, network pharmacological analysis revealed 94 common targets between rutin-associated wound healing and rutin-associated genes. Protein-protein interaction analysis identified key regulatory nodes, such as PIK3R1, PRKCA, and EGFR, which are central to the pathways that regulate cell proliferation, migration, angiogenesis, and inflammatory regulation. Enrichment analysis of gene ontology and KEGG pathways revealed that the PI3K-Akt, MAPK, VEGF, and AGE-RAGE signaling pathways were highly involved. Molecular docking showed good binding affinities of rutin to PIK3R1, PRKCA, and EGFR, which was also confirmed by 100 ns molecular dynamics simulations that revealed complex stability and favorable conformational behavior. Density functional theory analysis showed that the electronic characteristics were in line with the antioxidant activity and the strong intermolecular interactions. Together, these results demonstrate that rutin is a promising multifunctional topical wound-healing agent and provide mechanistic evidence for its use in topical therapeutic applications.
- Open Access
- 25 April 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 911-917
Herbal Therapies for Asthma: A Review of Traditional and Modern Perspectives
This review explores the potential of nine herbal plants - Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng in preventing and alleviating asthma symptoms. Asthma, a chronic inflammatory airway disease, often benefits from conventional treatments, but interest in natural alternatives is growing. Traditional herbal medicines show promise as alternative treatments and management strategies for asthma. Research highlights that many of these herbs exhibit anti-inflammatory, antioxidant, bronchodilatory, and immunomodulatory effects, which are crucial for addressing asthma’s underlying mechanisms. For instance, compounds like curcumin from Turmeric and thymoquinone from Black Seed have demonstrated anti-inflammatory and bronchodilatory properties. Ginger and Holy Basil have shown immunomodulatory effects that can help control airway inflammation. While current evidence often stems from in vitro, animal, or preliminary human studies, suggesting a role in symptomatic relief and potentially inhibiting disease progression, further rigorous clinical trials are needed to confirm their preventive efficacy and establish clear guidelines for their use as natural alternatives to conventional drugs, ultimately aiming to improve the quality of life for asthmatic patients. Major Finding: The review concludes that Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng show strong potential in alleviating asthma and evidence from laboratory, animal, and limited human studies indicates they may improve airway function and reduce inflammation with therapeutic efficacy in asthma management.
- 25 April 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 911-917
Open AccessHerbal Therapies for Asthma: A Review of Traditional and Modern Perspectives
This review explores the potential of nine herbal plants - Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng in preventing and alleviating asthma symptoms. Asthma, a chronic inflammatory airway disease, often benefits from conventional treatments, but interest in natural alternatives is growing. Traditional herbal medicines show promise as alternative treatments and management strategies for asthma. Research highlights that many of these herbs exhibit anti-inflammatory, antioxidant, bronchodilatory, and immunomodulatory effects, which are crucial for addressing asthma’s underlying mechanisms. For instance, compounds like curcumin from Turmeric and thymoquinone from Black Seed have demonstrated anti-inflammatory and bronchodilatory properties. Ginger and Holy Basil have shown immunomodulatory effects that can help control airway inflammation. While current evidence often stems from in vitro, animal, or preliminary human studies, suggesting a role in symptomatic relief and potentially inhibiting disease progression, further rigorous clinical trials are needed to confirm their preventive efficacy and establish clear guidelines for their use as natural alternatives to conventional drugs, ultimately aiming to improve the quality of life for asthmatic patients. Major Finding: The review concludes that Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng show strong potential in alleviating asthma and evidence from laboratory, animal, and limited human studies indicates they may improve airway function and reduce inflammation with therapeutic efficacy in asthma management.
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 27 (1) , 1-22
Impact and Significance of Viral Vectors for siRNA Delivery in the Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) remains a major challenge in developing effective treatments due to its complex pathophysiology, including the accumulation of amyloid-beta plaques and tau tangles. Small interfering RNA (siRNA) technology offers promise for targeted gene silencing, but effective delivery to the central nervous system remains a significant obstacle. Viral vectors have emerged as potent delivery vehicles for transporting siRNA to neural tissues. This review explores the utilization of viral vectors for siRNA delivery in AD, focusing on delivery strategies and challenges. We discuss the design and optimization of viral vectors, targeting strategies, and safety considerations. Additionally, we examine recent advancements and prospects for enhancing viral vector-mediated siRNA delivery in AD.
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 27 (1) , 1-22
Impact and Significance of Viral Vectors for siRNA Delivery in the Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) remains a major challenge in developing effective treatments due to its complex pathophysiology, including the accumulation of amyloid-beta plaques and tau tangles. Small interfering RNA (siRNA) technology offers promise for targeted gene silencing, but effective delivery to the central nervous system remains a significant obstacle. Viral vectors have emerged as potent delivery vehicles for transporting siRNA to neural tissues. This review explores the utilization of viral vectors for siRNA delivery in AD, focusing on delivery strategies and challenges. We discuss the design and optimization of viral vectors, targeting strategies, and safety considerations. Additionally, we examine recent advancements and prospects for enhancing viral vector-mediated siRNA delivery in AD.
- 31 July 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (1) , 1177-1195
A combined network pharmacology and experimental approach to investigate the mechanisms of curcumin on diabetes through the adipocytokine signaling pathway
The present investigation aims to establish the mechanism of curcumin in targeting diabetes and obesity, specifically through its effects on Adipoq, Il-6, and Tnf-α, using network pharmacology-based in silico analysis, followed by in silico validation. Target genes associated with diabetes and obesity were identified using GeneCards and SwissTargetPrediction, revealing that curcumin modulates Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway, suggesting a novel therapeutic mechanism. In this study, the effects of curcumin on diabetic rats were evaluated by assessing blood sugar levels (BSL), HbA1c, insulin levels, and adipocytokine expression. Diabetes was induced, and rats were treated with curcumin or pioglitazone for 4 weeks, followed by biochemical analysis. The in silico experimental findings demonstrate that curcumin is more effective than pioglitazone in managing obesity-induced diabetes by modulating the mRNA expression of adipocytokines. These results align with the predictions from in silico analysis, supporting the hypothesis that curcumin targets Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway. This study introduces a targeted approach for diabetes management by modulating adipocytokines with curcumin. The integration of in silico analysis with in silico validation provides a comprehensive framework for developing novel therapeutic strategies against obesity-induced diabetes. Graphical abstract
- 31 July 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (1) , 1177-1195
A combined network pharmacology and experimental approach to investigate the mechanisms of curcumin on diabetes through the adipocytokine signaling pathway
The present investigation aims to establish the mechanism of curcumin in targeting diabetes and obesity, specifically through its effects on Adipoq, Il-6, and Tnf-α, using network pharmacology-based in silico analysis, followed by in silico validation. Target genes associated with diabetes and obesity were identified using GeneCards and SwissTargetPrediction, revealing that curcumin modulates Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway, suggesting a novel therapeutic mechanism. In this study, the effects of curcumin on diabetic rats were evaluated by assessing blood sugar levels (BSL), HbA1c, insulin levels, and adipocytokine expression. Diabetes was induced, and rats were treated with curcumin or pioglitazone for 4 weeks, followed by biochemical analysis. The in silico experimental findings demonstrate that curcumin is more effective than pioglitazone in managing obesity-induced diabetes by modulating the mRNA expression of adipocytokines. These results align with the predictions from in silico analysis, supporting the hypothesis that curcumin targets Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway. This study introduces a targeted approach for diabetes management by modulating adipocytokines with curcumin. The integration of in silico analysis with in silico validation provides a comprehensive framework for developing novel therapeutic strategies against obesity-induced diabetes. Graphical abstract
- Open Access
- 12 March 2025
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 16 (2) , 101095
Targeting cell cycle arrest in breast cancer by phytochemicals from Caryto urens L. fruit ethyl acetate fraction: in silico and in vitro validation
- 12 March 2025
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 16 (2) , 101095
Open AccessTargeting cell cycle arrest in breast cancer by phytochemicals from Caryto urens L. fruit ethyl acetate fraction: in silico and in vitro validation
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Nanoscience
- Vol. 21 (4) , 640-657
Weaving the Future of Topical Medicine: A Journey with Electrospinning Nanofibre Scaffolds
The pharmaceutical sciences are gradually shielding mankind from a plethora of deadly but as-of-yet-undiscovered ailments. Many diseases, some of which can be fatal, have their initial line of defence on the skin. A significant challenge for scientists is the development of appropriate pharmacological formulations for transdermal drug administration. Low side effect risk reduces first-pass impact, and good patient compliance makes transdermal distribution superior to oral delivery. This is why transdermal medication delivery is so important. Thanks to advancements in pharmaceutical delivery systems, the skin can now absorb medications more effectively. Researchers from different parts of the globe have investigated many different kinds of medications as possible transdermal delivery routes using electrospinning nanofibres. The skin can more easily absorb therapeutic compounds thanks to the nanofibres' ability to concentrate them. It is possible to load hydrophilic and lipophilic medications onto polymeric nanofibres. Another option is the transdermal distribution of biopolymer nanofibres. Over long periods of time, they control the release of medicinal substances. Nanofibres and nanoparticles allow for the controlled release of both hydrophobic and hydrophilic drugs. Transdermal and topical medication delivery using polymeric electrospinning nanofibres laden with nanoparticles and medicines is the subject of this research review. After that, we'll look at some practical instances of engineers using electrospinning fibres to control the release of drugs in reaction to environmental and internal factors. Afterwards, we will quickly go over the latest developments in tissue engineering, hard tissue engineering (which includes repairing musculoskeletal systems, bones, and cartilage), and cancer therapy that uses electrospin nanofiber scaffolds to control the distribution of drugs. Thanks to recent advancements in medicine and pharmaceuticals, nanofibres may soon be able to transport a wide variety of drugs, allowing for more targeted methods of cellular regeneration and topical medication delivery.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Nanoscience
- Vol. 21 (4) , 640-657
Weaving the Future of Topical Medicine: A Journey with Electrospinning Nanofibre Scaffolds
The pharmaceutical sciences are gradually shielding mankind from a plethora of deadly but as-of-yet-undiscovered ailments. Many diseases, some of which can be fatal, have their initial line of defence on the skin. A significant challenge for scientists is the development of appropriate pharmacological formulations for transdermal drug administration. Low side effect risk reduces first-pass impact, and good patient compliance makes transdermal distribution superior to oral delivery. This is why transdermal medication delivery is so important. Thanks to advancements in pharmaceutical delivery systems, the skin can now absorb medications more effectively. Researchers from different parts of the globe have investigated many different kinds of medications as possible transdermal delivery routes using electrospinning nanofibres. The skin can more easily absorb therapeutic compounds thanks to the nanofibres' ability to concentrate them. It is possible to load hydrophilic and lipophilic medications onto polymeric nanofibres. Another option is the transdermal distribution of biopolymer nanofibres. Over long periods of time, they control the release of medicinal substances. Nanofibres and nanoparticles allow for the controlled release of both hydrophobic and hydrophilic drugs. Transdermal and topical medication delivery using polymeric electrospinning nanofibres laden with nanoparticles and medicines is the subject of this research review. After that, we'll look at some practical instances of engineers using electrospinning fibres to control the release of drugs in reaction to environmental and internal factors. Afterwards, we will quickly go over the latest developments in tissue engineering, hard tissue engineering (which includes repairing musculoskeletal systems, bones, and cartilage), and cancer therapy that uses electrospin nanofiber scaffolds to control the distribution of drugs. Thanks to recent advancements in medicine and pharmaceuticals, nanofibres may soon be able to transport a wide variety of drugs, allowing for more targeted methods of cellular regeneration and topical medication delivery.
- Open Access
Unravelling the Molecular Footprints of Diabetic Foot Ulcers: In Silico Discovery of Key Protein and MicroRNA Signatures
Diabetic foot ulcers (DFUs) present a significant clinical challenge, characterized by chronic inflammation and impaired wound healing. This study employs Gene Ontology (GO) analysis to identify critical biological processes, molecular functions, cellular components, and pathways associated with DFUs, aiming to uncover novel therapeutic targets. The analysis reveals significant enrichment in biological processes such as Positive Regulation of miRNA Transcription and Regulation of miRNA Transcription, highlighting the crucial role of microRNAs, including hsa-miR-34a-5p, hsa-miR-155-5p, hsa-miR-17-5p, hsa-miR-29b-3p, hsa-miR-7-5p, hsa-miR-1-3p, and hsa-miR-23b-3p, in regulating wound healing and inflammation. Enriched molecular functions, such as DNA-binding Transcription Activator Activity and Protein Phosphatase Binding, suggest that targeting genes like TP53, GAPDH, AKT1, MYC, TNF, EGFR, STAT3, FN1, VEGFA, and JUN could modulate critical cellular processes and improve DFU management. The analysis also identifies key cellular components, including Vesicle and Platelet Alpha Granule Lumen, as crucial for cellular transport and signaling, suggesting that interventions targeting these components could enhance wound repair. Furthermore, enriched pathways such as Proteoglycans in Cancer and Human Cytomegalovirus Infection indicate potential mechanisms and viral influences relevant to DFUs. These findings provide a comprehensive framework for developing targeted therapies that address the multifaceted pathology of DFUs, offering promising avenues for improving patient outcomes and advancing wound healing strategies.
Open AccessUnravelling the Molecular Footprints of Diabetic Foot Ulcers: In Silico Discovery of Key Protein and MicroRNA Signatures
Diabetic foot ulcers (DFUs) present a significant clinical challenge, characterized by chronic inflammation and impaired wound healing. This study employs Gene Ontology (GO) analysis to identify critical biological processes, molecular functions, cellular components, and pathways associated with DFUs, aiming to uncover novel therapeutic targets. The analysis reveals significant enrichment in biological processes such as Positive Regulation of miRNA Transcription and Regulation of miRNA Transcription, highlighting the crucial role of microRNAs, including hsa-miR-34a-5p, hsa-miR-155-5p, hsa-miR-17-5p, hsa-miR-29b-3p, hsa-miR-7-5p, hsa-miR-1-3p, and hsa-miR-23b-3p, in regulating wound healing and inflammation. Enriched molecular functions, such as DNA-binding Transcription Activator Activity and Protein Phosphatase Binding, suggest that targeting genes like TP53, GAPDH, AKT1, MYC, TNF, EGFR, STAT3, FN1, VEGFA, and JUN could modulate critical cellular processes and improve DFU management. The analysis also identifies key cellular components, including Vesicle and Platelet Alpha Granule Lumen, as crucial for cellular transport and signaling, suggesting that interventions targeting these components could enhance wound repair. Furthermore, enriched pathways such as Proteoglycans in Cancer and Human Cytomegalovirus Infection indicate potential mechanisms and viral influences relevant to DFUs. These findings provide a comprehensive framework for developing targeted therapies that address the multifaceted pathology of DFUs, offering promising avenues for improving patient outcomes and advancing wound healing strategies.